Wong, Y., Raghavendra, A. S., Hatzis, C., Irizarry, J. P., Vega, T., Horowitz, N., . . . Murthy, R. K. (2018). Long‐Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2‐Targeted Therapy. Oncologist.
Chicago ZitierstilWong, Yao, et al. "Long‐Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated With HER2‐Targeted Therapy." Oncologist 2018.
MLA ZitierstilWong, Yao, et al. "Long‐Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated With HER2‐Targeted Therapy." Oncologist 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.